Will Lyell Immunopharma Inc (LYEL) Outperform the Rest of the Stocks in the Healthcare Sector?

A rating of 77 puts Lyell Immunopharma Inc (LYEL) near the top of the Healthcare sector according to InvestorsObserver. Lyell Immunopharma Inc's score of 77 means that it ranks higher than 77% of stocks in the sector. In addition, its overall score of 42 ranks it higher than 42% of all stocks.

LYEL has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on LYEL!

See Full LYEL Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Lyell Immunopharma Inc Stock Today?

Lyell Immunopharma Inc (LYEL) stock is trading at $1.91 as of 1:19 PM on Friday, Nov 17, a rise of $0.03, or 1.87% from the previous closing price of $1.87. The stock has traded between $1.86 and $2.03 so far today. Volume today is low. So far 367,740 shares have traded compared to average volume of 954,120 shares. Click Here to get the full Stock Report for Lyell Immunopharma Inc stock.